Figure 3
From: Role and expression of FRS2 and FRS3 in prostate cancer
Effect of dual targeting of FRS2 and FRS3 in cancer and benign cells. A: Immunoblot analysis showing representative dual down-regulation of FRS2 and FRS3 protein in PC3 cell line and corresponding proliferation assay stimulated with full media. B: Down-regulation of FRS2 and FRS3 in DU145 cell line and corresponding proliferation assay stimulated with full media. C: Down-regulation of FRS2 and FRS3 in benign PNT2 cell line and corresponding proliferation assay stimulated with full media. *p < 0.005. siFRS2/3- siRNA against FRS2 and FRS3